Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening.

Semedo, Lenira, Lifford, Kate J ORCID: https://orcid.org/0000-0002-9782-2080, Edwards, Adrian ORCID: https://orcid.org/0000-0002-6228-4446, Seddon, Kathy, Brain, Kate ORCID: https://orcid.org/0000-0001-9296-9748, Smits, Stephanie ORCID: https://orcid.org/0000-0001-7897-150X and Dolwani, Sunil ORCID: https://orcid.org/0000-0002-3113-5472 2021. Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening. BMC Medical Informatics and Decision Making 21 , 165. 10.1186/s12911-021-01523-9

	PDF - Published Version Available under License Creative Commons Attribution. Download (1MB)
	Archive (ZIP) - Supplemental Material Available under License Creative Commons Attribution. Download (483kB)

Abstract

Background Several epidemiological and cohort studies suggest that regular low-dose aspirin use independently reduces the long-term incidence and risk of colorectal cancer deaths by approximately 20%. However, there are also risks to aspirin use, mainly gastrointestinal bleeding and haemorrhagic stroke. Making informed decisions depends on the ability to understand and weigh up benefits and risks of available options. A decision aid to support people to consider aspirin therapy alongside participation in the NHS bowel cancer screening programme may have an additional impact on colorectal cancer prevention. This study aims to develop and user-test a brief decision aid about aspirin to enable informed decision-making for colorectal screening-eligible members of the public. Methods We undertook a qualitative study to develop an aspirin decision aid leaflet to support bowel screening responders in deciding whether to take aspirin to reduce their risk of colorectal cancer. The iterative development process involved two focus groups with public members aged 60–74 years (n = 14) and interviews with clinicians (n = 10). Interviews (n = 11) were used to evaluate its utility for decision-making. Analysis was conducted using a framework approach. Results Overall, participants found the decision aid acceptable and useful to facilitate decision-making. They expressed a need for individualised risk information, more detail about the potential risks of aspirin, and preferred risk information presented in pictograms when offered different options. Implementation pathways were discussed, including the possibility of involving different clinicians in the process such as GPs and/or community pharmacists. A range of potentially effective timepoints for sending out the decision aid were identified. Conclusion An acceptable and usable decision aid was developed to support decisions about aspirin use to prevent colorectal cancer.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This article is licensed under a Creative Commons Attribution 4.0 International License
Publisher:	BioMed Central
ISSN:	1472-6947
Date of First Compliant Deposit:	20 May 2021
Date of Acceptance:	7 May 2021
Last Modified:	06 Jan 2024 04:14
URI:	https://orca.cardiff.ac.uk/id/eprint/141476

Actions (repository staff only)

Edit Item